Author

Eva van den Berg

University Medical Center GroningenPrimary ORCID profile (0009-0000-6696-090X · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Eva van den BergiD2 papers · University of Canterbury

Biology Disciplines

Click to filter author papers

Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:human· 1 Assay:long-read sequencing· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Arjen J. Scheper· 1 shared Birgit Sikkema‐RaddatziD· 1 shared Cleo C. van DiemeniD· 1 shared Eddy N. de BoeriD· 1 shared Laura Bosscher· 1 shared Lennart F. JohanssoniD· 1 shared Nettie Rietema· 1 shared Nine V.A.M. KnoersiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Arjen J. Scheper

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cas9-directed long-read sequencing to resolve optical genome mapping findings in leukemia diagnostics.

Eddy N. de Boer, Vincent Vroom, Arjen J. Scheper, Lennart F. Johansson, Laura Bosscher, Nettie Rietema, Sabrina Z. Jan, Nine V.A.M. Knoers, Birgit Sikkema‐Raddatz, Eva van den Berg, Cleo C. van Diemen

This study uses Cas9-directed long-read sequencing to validate and refine optical genome mapping findings in leukemia diagnostics, improving breakpoint resolution and clinical relevance assessment.

Scientific Reports · Apr 11, 2024Peer-reviewedGenetics